RxSight (RXST) Revenue (2020 - 2026)

RxSight has reported Revenue for 7 years, with the latest figure at $30.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 18.48% year-over-year to $30.9 million; the trailing twelve-month figure through Mar 2026 stood at $127.5 million (down 14.05% YoY), and the FY2025 full-year result was $134.5 million, down 3.89% from the prior year.
• Revenue for Q1 2026 stood at $30.9 million, down from $32.6 million in the prior quarter.
• The five-year high for Revenue was $40.2 million in Q4 2024, with the low at $8.9 million in Q1 2022.
• Historically, Revenue has averaged $26.1 million across 5 years, with a median of $29.5 million in 2024.
• Annual changes were most pronounced in 2022 — Revenue surged 156.66% — and 2025, when it decreased 18.91%.
• RxSight's Revenue stood at $16.1 million in 2022, then surged by 77.65% to $28.6 million in 2023, then jumped by 40.71% to $40.2 million in 2024, then decreased by 18.91% to $32.6 million in 2025, then declined by 5.26% to $30.9 million in 2026.
• The last three Revenue figures came in at $30.9 million (Q1 2026), $32.6 million (Q4 2025), and $30.3 million (Q3 2025), per Business Quant data.